Finding 949035 (2023-002)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-03-06
Audit: 293672
Auditor: Mahoney

AI Summary

  • Core Issue: There was a lack of review on payroll transactions, leading to significant errors in employee benefits that went undetected until after a key HR employee's termination.
  • Impacted Requirements: Internal controls over payroll processes were inadequate, increasing the risk of misstatements and potential fraud.
  • Recommended Follow-Up: Management should ensure qualified personnel review payroll and benefits processes, with timely and documented reviews in place.

Finding Text

2023-002 Lack of Review on Payroll Transactions/Payroll Files Significant Deficiency Criteria – Management is responsible for establishing and maintaining internal controls over the payroll process. A key element of internal control for payroll is the review of biweekly payroll transactions and the periodic review of personnel files. Condition – Management discovered after the termination of a former Human Resources employee that there were significant errors in benefits. These were all corrected by year-end, but were not discovered and corrected until after her termination (i.e. Employee Benefit Plan errors, health insurance errors, life insurance errors, etc.). These errors crossed multiple years. Cause – The HR Director the Organization inherited in the merger with House of Charities in 2021 was not qualified to do her job, but this was not obvious to management until after she left the Organization. Effect – As a result of this condition, the Organization is exposed to an increased risk that misstatements (whether caused by error or fraud) may occur and not be prevented or detected by management on a timely basis. For example, incorrect costs may be paid due to not properly terminating benefits for former employees or not properly applying pay rate changes, or employees may not be receiving the benefits they are due because new employees were not added properly. Recommendation – We encourage the Organization’s management to review their processes related to payroll and benefits to ensure the individual responsible for reviewing this information is qualified to perform the function and that the reviews take place timely and are documented appropriately. Auditee's comments and response – Management agrees with the finding. Management is reviewing and assessing all of the payroll and human resources functions, and HR plans to hire additional staff. They expect to fully implement the new process by July 1, 2024. Responsible party for corrective action: Laura Straw, Finance Director Repeat Finding: No

Categories

Internal Control / Segregation of Duties Significant Deficiency

Other Findings in this Audit

  • 372584 2023-001
    Material Weakness Repeat
  • 372585 2023-001
    Material Weakness Repeat
  • 372586 2023-001
    Material Weakness Repeat
  • 372587 2023-001
    Material Weakness Repeat
  • 372588 2023-001
    Material Weakness Repeat
  • 372589 2023-001
    Material Weakness Repeat
  • 372590 2023-001
    Material Weakness Repeat
  • 372591 2023-001
    Material Weakness Repeat
  • 372592 2023-002
    Significant Deficiency
  • 372593 2023-002
    Significant Deficiency
  • 372594 2023-002
    Significant Deficiency
  • 372595 2023-002
    Significant Deficiency
  • 372596 2023-002
    Significant Deficiency
  • 372597 2023-002
    Significant Deficiency
  • 372598 2023-002
    Significant Deficiency
  • 372599 2023-002
    Significant Deficiency
  • 372600 2023-003
    Significant Deficiency
  • 372601 2023-003
    Significant Deficiency
  • 372602 2023-003
    Significant Deficiency
  • 372603 2023-003
    Significant Deficiency
  • 372604 2023-003
    Significant Deficiency
  • 372605 2023-003
    Significant Deficiency
  • 372606 2023-003
    Significant Deficiency
  • 372607 2023-003
    Significant Deficiency
  • 372608 2023-004
    Material Weakness Repeat
  • 372609 2023-004
    Material Weakness Repeat
  • 372610 2023-004
    Material Weakness Repeat
  • 372611 2023-004
    Material Weakness Repeat
  • 372612 2023-004
    Material Weakness Repeat
  • 372613 2023-004
    Material Weakness Repeat
  • 372614 2023-004
    Material Weakness Repeat
  • 372615 2023-004
    Material Weakness Repeat
  • 372616 2023-005
    Significant Deficiency Repeat
  • 372617 2023-005
    Significant Deficiency Repeat
  • 372618 2023-005
    Significant Deficiency Repeat
  • 372619 2023-005
    Significant Deficiency Repeat
  • 372620 2023-005
    Significant Deficiency Repeat
  • 372621 2023-006
    Significant Deficiency
  • 372622 2023-006
    Significant Deficiency
  • 372623 2023-006
    Significant Deficiency
  • 372624 2023-006
    Significant Deficiency
  • 372625 2023-006
    Significant Deficiency
  • 949026 2023-001
    Material Weakness Repeat
  • 949027 2023-001
    Material Weakness Repeat
  • 949028 2023-001
    Material Weakness Repeat
  • 949029 2023-001
    Material Weakness Repeat
  • 949030 2023-001
    Material Weakness Repeat
  • 949031 2023-001
    Material Weakness Repeat
  • 949032 2023-001
    Material Weakness Repeat
  • 949033 2023-001
    Material Weakness Repeat
  • 949034 2023-002
    Significant Deficiency
  • 949036 2023-002
    Significant Deficiency
  • 949037 2023-002
    Significant Deficiency
  • 949038 2023-002
    Significant Deficiency
  • 949039 2023-002
    Significant Deficiency
  • 949040 2023-002
    Significant Deficiency
  • 949041 2023-002
    Significant Deficiency
  • 949042 2023-003
    Significant Deficiency
  • 949043 2023-003
    Significant Deficiency
  • 949044 2023-003
    Significant Deficiency
  • 949045 2023-003
    Significant Deficiency
  • 949046 2023-003
    Significant Deficiency
  • 949047 2023-003
    Significant Deficiency
  • 949048 2023-003
    Significant Deficiency
  • 949049 2023-003
    Significant Deficiency
  • 949050 2023-004
    Material Weakness Repeat
  • 949051 2023-004
    Material Weakness Repeat
  • 949052 2023-004
    Material Weakness Repeat
  • 949053 2023-004
    Material Weakness Repeat
  • 949054 2023-004
    Material Weakness Repeat
  • 949055 2023-004
    Material Weakness Repeat
  • 949056 2023-004
    Material Weakness Repeat
  • 949057 2023-004
    Material Weakness Repeat
  • 949058 2023-005
    Significant Deficiency Repeat
  • 949059 2023-005
    Significant Deficiency Repeat
  • 949060 2023-005
    Significant Deficiency Repeat
  • 949061 2023-005
    Significant Deficiency Repeat
  • 949062 2023-005
    Significant Deficiency Repeat
  • 949063 2023-006
    Significant Deficiency
  • 949064 2023-006
    Significant Deficiency
  • 949065 2023-006
    Significant Deficiency
  • 949066 2023-006
    Significant Deficiency
  • 949067 2023-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.267 Continuum of Care Program $326,522
14.231 Emergency Solutions Grant Program $118,642